Alexander finn Site

Need help? Text us, and a team member will reply in mins +1 123 456 7891

Have questions about bpc-157?
Text us: +1 123456789

Semaglutide

Nootropic Compound

Price range: $39.00 through $349.00

Quantity

Research Use Only

These products are for laboratory research only and not intended for medical use. They are not FDA-approved to diagnose, treat, cure, or prevent any disease. By purchasing, you certify they will be used solely for research and not for human or animal consumption.

What is Semaglutide?

Semaglutide, also referred to as Semaglutide, is a GLP-1 receptor agonist studied for its involvement in metabolic signaling, appetite-related pathways, and insulin response mechanisms. In laboratory research, it is examined for its role in regulating glucose uptake, energy balance, and endocrine activity through peptide-based signaling pathways.

Made in the USA

Quality controlled from start to finish.
No outsourcing.

Need Help?

Send us a message.

Semaglutide Overview
Semaglutide, commonly known as Semaglutide, is a synthetic peptide analog of glucagon-like peptide-1 (GLP-1) that has been structurally modified to extend its biological activity. In laboratory and preclinical models, it is investigated for its ability to activate GLP-1 receptors, influence insulin signaling, and regulate cellular pathways related to glucose metabolism and endocrine system function.

History
Research into GLP-1 biology began in the 1980s following the discovery of its role in glucose regulation and endocrine signaling processes. Early synthetic GLP-1 receptor agonists demonstrated the potential to prolong receptor activation, though their short half-life limited long-term study. Semaglutide was later developed with targeted structural modifications at specific amino acid positions to improve receptor binding and extend duration of activity, allowing researchers to further explore incretin signaling and metabolic pathways in experimental models.

Semaglutide Structure

CAS #: 910463-68-2
Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉
Molecular Weight: 4113.6 g/mol
PubChem ID: 56843331

Research Findings

Sema, also known as Semaglutide, has been investigated in metabolic, endocrine, and cardiovascular research models, with studies examining its role in glucose regulation, insulin signaling, and metabolic pathway activity. Research also explores its involvement in lipid metabolism, appetite signaling, and cardiovascular-related biological processes within preclinical and clinical environments.

Key Areas of Research:

  • Metabolic: Glucose metabolism, insulin signaling, energy balance
  • Endocrine: GLP-1 receptor pathways, hormone regulation
  • Cardiovascular: Lipid metabolism, cholesterol pathways, systemic effects

Together, these observations indicate broad experimental relevance for Semaglutide across metabolic, endocrine, and cardiovascular biological systems. Through its interaction with GLP-1 signaling and its influence on glucose and lipid pathways, Semaglutide provides a useful framework for laboratory research focused on metabolic regulation, cardiovascular biology, and systemic physiological stability.

Description

Semaglutide Overview
Semaglutide, commonly known as Semaglutide, is a synthetic peptide analog of glucagon-like peptide-1 (GLP-1) that has been structurally modified to extend its biological activity. In laboratory and preclinical models, it is investigated for its ability to activate GLP-1 receptors, influence insulin signaling, and regulate cellular pathways related to glucose metabolism and endocrine system function.

History
Research into GLP-1 biology began in the 1980s following the discovery of its role in glucose regulation and endocrine signaling processes. Early synthetic GLP-1 receptor agonists demonstrated the potential to prolong receptor activation, though their short half-life limited long-term study. Semaglutide was later developed with targeted structural modifications at specific amino acid positions to improve receptor binding and extend duration of activity, allowing researchers to further explore incretin signaling and metabolic pathways in experimental models.

Semaglutide Structure

CAS #: 910463-68-2
Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉
Molecular Weight: 4113.6 g/mol
PubChem ID: 56843331

Research Findings

Sema, also known as Semaglutide, has been investigated in metabolic, endocrine, and cardiovascular research models, with studies examining its role in glucose regulation, insulin signaling, and metabolic pathway activity. Research also explores its involvement in lipid metabolism, appetite signaling, and cardiovascular-related biological processes within preclinical and clinical environments.

Key Areas of Research:

  • Metabolic: Glucose metabolism, insulin signaling, energy balance
  • Endocrine: GLP-1 receptor pathways, hormone regulation
  • Cardiovascular: Lipid metabolism, cholesterol pathways, systemic effects

Together, these observations indicate broad experimental relevance for Semaglutide across metabolic, endocrine, and cardiovascular biological systems. Through its interaction with GLP-1 signaling and its influence on glucose and lipid pathways, Semaglutide provides a useful framework for laboratory research focused on metabolic regulation, cardiovascular biology, and systemic physiological stability.

Additional information

Pcs

Pack of 10, Single Vial

Strength

10mg

Reviews

There are no reviews yet.

Be the first to review “Semaglutide”

Your email address will not be published. Required fields are marked *

Text us, our dedicated team is here to help.

Reach out and get a response within minutes

+1 123456789